Patient centricity: lip service or genuine commitment? A qualitative examination of the pharmaceutical industry

Author:

Katsanis Lea Prevel,Pitta Dennis,Morinville Anne

Abstract

Purpose The purpose of this study is two-fold: first, to identify the degree of adoption of patient centricity in the pharmaceutical industry and second, to understand how the industry operationalizes this strategy. It is an important shift in the industry because of its central focus on the patient. Design/methodology/approach A content analysis was used based on publicly available documentation that includes industry publications, company and brand websites and clinical trial publications to identify the frequency of words used to describe patient centricity. Findings The key finding of this study is that the leading pharmaceutical firms overwhelmingly use patient support/access programs as the primary method of implementing patient centric strategies. Research limitations/implications Future research is needed to identify what impact these strategies have on patients; and whether or not these strategies have an impact on lowering drug prices and improved clinical outcomes for patients. Practical implications Future research is needed to identify what impact these strategies have on patients; and whether or not these strategies have an impact on lowering drug prices and improved clinical outcomes for patients. Limitations include the reliance on publicly available documentation. Social implications Pharmaceutical firms need to be aware that their publically available profile suggests a one-dimensional approach to patient centricity and this may influence the way patients, physicians and policymakers view their attitudes toward patients. This study is the first to systematically examine the activities of leading pharmaceutical firms with respect to the adoption and implementation of patient-centric strategies in a comprehensive fashion. Originality/value This study is the first to systematically examine the activities of leading pharmaceutical firms with respect to the adoption and implementation of patient-centric strategies in a comprehensive fashion.

Publisher

Emerald

Subject

Marketing,Health Policy

Reference63 articles.

1. Alsumidaie, M. (2016), “FDA and industry share perspectives on patient centricity”, available at: www.appliedclinicaltrialsonline.com/fda-industry-share-perspectives-patient-centricity (accessed 11 November 2018).

2. The evolution of patient centricity;Applied Clinical Trials,2019

3. The ins and outs of incorporating patient centricity in drug development;Anonymous;Pharmaceutical Executive,2020

4. Atkins, R.J., Ronn, L., Lallas, N. and Mcleod, H. (2014), “Walking the talk’ in patient-centric pharma”, available at: http://knowledge.senndelaney.com/docs/thought_papers/pdf/Heidrick_SennDelaney_patientcentric.pdf (accessed 11 November 2018).

5. Clinical trial optimization;Applied Clinical Trials,2020

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3